BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 25700239)

  • 21. Giant cell tumor of the thoracic spine completely removed by total spondylectomy after neoadjuvant denosumab therapy.
    Yonezawa N; Murakami H; Kato S; Takeuchi A; Tsuchiya H
    Eur Spine J; 2017 May; 26(Suppl 1):236-242. PubMed ID: 28396950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Minimally Invasive Spinal Stabilization with Denosumab before Total Spondylectomy for a Collapsing Lower Lumbar Spinal Giant Cell Tumor.
    Minato K; Hirano T; Kawashima H; Yamagishi T; Watanabe K; Ohashi M; Ogose A; Endo N
    Acta Med Okayama; 2021 Feb; 75(1):95-101. PubMed ID: 33649620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone.
    Branstetter DG; Nelson SD; Manivel JC; Blay JY; Chawla S; Thomas DM; Jun S; Jacobs I
    Clin Cancer Res; 2012 Aug; 18(16):4415-24. PubMed ID: 22711702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multimodal Management of Combined Posterior and Anterior Surgical Approach and Postoperative Pharmacological Therapy for Giant Cell Tumor of the Cervical Spine Encasing the Vertebral Artery: A Technical Case Report.
    Tsuji Y; Fukuo Y; Kanemitsu T; Katayama Y; Yagi R; Hiramatsu R; Kameda M; Nonoguchi N; Furuse M; Kawabata S; Baba I; Takami T; Wanibuchi M
    Neurol Med Chir (Tokyo); 2022 Sep; 62(9):438-443. PubMed ID: 36031352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of Denosumab in Endoscopic Endonasal Treatment for Juvenile Clival Giant Cell Tumor: A Case Report and Review of the Literature.
    Inoue A; Ohnishi T; Kohno S; Nishikawa M; Nishida N; Ohue S
    World Neurosurg; 2016 Jul; 91():674.e1-6. PubMed ID: 27113403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study.
    Chawla S; Henshaw R; Seeger L; Choy E; Blay JY; Ferrari S; Kroep J; Grimer R; Reichardt P; Rutkowski P; Schuetze S; Skubitz K; Staddon A; Thomas D; Qian Y; Jacobs I
    Lancet Oncol; 2013 Aug; 14(9):901-8. PubMed ID: 23867211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Giant Cell Lesions of the Maxillofacial Skeleton Express RANKL by RNA In Situ Hybridization Regardless of Histologic Pattern.
    Stagner AM; Sajed DP; Nielsen GP; Ebb DH; Faquin WC; Chebib I; Rivera MN; Ting DT; Resnick CM; Peacock ZS; Kaban LB; Deshpande V
    Am J Surg Pathol; 2019 Jun; 43(6):819-826. PubMed ID: 30998511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical features and prognostic factors of pediatric spine giant cell tumors: report of 31 clinical cases in a single center.
    Jia Q; Chen G; Cao J; Yang X; Zhou Z; Wei H; Liu T; Xiao J
    Spine J; 2019 Jul; 19(7):1232-1241. PubMed ID: 30776487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes following attempted en bloc resection of cervical chordomas in the C-1 and C-2 region versus the subaxial region: a multiinstitutional experience.
    Molina CA; Ames CP; Chou D; Rhines LD; Hsieh PC; Zadnik PL; Wolinsky JP; Gokaslan ZL; Sciubba DM
    J Neurosurg Spine; 2014 Sep; 21(3):348-56. PubMed ID: 24926926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of denosumab on pain and analgesic use in giant cell tumor of bone: interim results from a phase II study.
    Martin-Broto J; Cleeland CS; Glare PA; Engellau J; Skubitz KM; Blum RH; Ganjoo KN; Staddon A; Dominkus M; Feng A; Qian Y; Braun A; Jacobs I; Chung K; Atchison C
    Acta Oncol; 2014 Sep; 53(9):1173-9. PubMed ID: 24834795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combining of serial embolization and denosumab for large sacropelvic giant cell tumor: Case report of 3 cases.
    Ji T; Yang Y; Wang Y; Sun K; Guo W
    Medicine (Baltimore); 2017 Aug; 96(33):e7799. PubMed ID: 28816971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Denosumab for the treatment of giant cell tumor of the bone.
    Brodowicz T; Hemetsberger M; Windhager R
    Future Oncol; 2015; 11(13):1881-94. PubMed ID: 26161925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morphologic evaluation of the effect of denosumab on giant cell tumors of bone and a new grading scheme.
    Erdogan KE; DevecI MA; Paydas S; Gonlusen G
    Pol J Pathol; 2016; 67(4):392-397. PubMed ID: 28547968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Administration of sodium ibandronate in the treatment of complicated giant cell tumor of the spine.
    Zhang W; Zhang Y; Li P; Rhodesm SD; Wang Y; Xue X; Dong Y; Ding W; Shen Y; Zhang B
    Spine (Phila Pa 1976); 2011 Aug; 36(17):E1166-72. PubMed ID: 21785300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recommencement of Denosumab for Unresectable Giant Cell Tumor of the Cervical Spine: A Case Report.
    Law GW; Yeo NEM; Howe TS; Tan YZ; Tan SB; Siddiqui MMA
    Spine (Phila Pa 1976); 2018 May; 43(9):E551-E556. PubMed ID: 29016442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment and outcome of primary aggressive giant cell tumor in the spine.
    Yin H; Yang X; Xu W; Li B; Li B; Wang T; Meng T; Wang P; Liu T; Zhou W; Xiao J
    Eur Spine J; 2015 Aug; 24(8):1747-53. PubMed ID: 25631339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can Denosumab cure giant cell tumors of the spine? A case report and literature review.
    Xará-Leite F; Coutinho L; Fleming C; Magalhães M; Oliveira V; Rodrigues-Pinto R; Cardoso P
    Eur J Orthop Surg Traumatol; 2020 Jan; 30(1):19-23. PubMed ID: 31529151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RANKL, denosumab, and giant cell tumor of bone.
    Thomas DM
    Curr Opin Oncol; 2012 Jul; 24(4):397-403. PubMed ID: 22581354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Giant Cell Tumor of Cervical Spine Presenting as Acute Asphyxia: Successful Surgical Resection After Down-Staging With Denosumab.
    Kumar R; Meis JM; Amini B; McEnery KW; Madewell JE; Rhines LD; Benjamin RS
    Spine (Phila Pa 1976); 2017 May; 42(10):E629-E632. PubMed ID: 27792106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors affecting prognosis of patients with giant cell tumors of the mobile spine: retrospective analysis of 102 patients in a single center.
    Xu W; Li X; Huang W; Wang Y; Han S; Chen S; Xu L; Yang X; Liu T; Xiao J
    Ann Surg Oncol; 2013 Mar; 20(3):804-10. PubMed ID: 23096699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.